SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

Share Price is delayed by 15 minutes
Get Live Data
77.00    0.00 (0.00%)
Bid:
77.00
Ask:
78.20
Spread: 1.20 (1.558%)
Market Cap: £187.07m
AXS Live PriceLast checked at - London Stock Exchange

Intraday Accsys Tech Share Chart

Akzo Nobel Endorsement

3 Nov 2005 07:00

Accsys Technologies PLC03 November 2005 3 November 2005 AIM: AXS Ground-breaking research sets new standard for wood maintenance as Accoya gets the thumbs up from Akzo Nobel. Accsys Technologies PLC ("Accsys" or "the Company") reports that Akzo NobelDecorative Coatings' subsidiary, Sikkens Joinery (Netherlands), has announcedground-breaking results of a 10 year collaborative research programme whichshows that Accoya, the 'new wood species' developed by Accsys' wholly ownedsubsidiary, Titan Wood, can last ten years or longer without the need forrepainting. The development of extended maintenance-free periods willcontribute significantly to the protection of rainforests by offering a highlydurable, non-toxic and environmentally friendly alternative to tropicalhardwoods. The joint initiative between Titan Wood BV (www.titanwood.com) and SikkensJoinery, a leading provider of high quality paint systems, shows that Accoyacould set new standards for the wood industry by significantly reducing the costand therefore the environmental impact of maintaining products such as windows,doors and cladding. Accoya is made using a process which effectively converts softwoods andnon-durable hardwoods into an environmentally compatible 'new wood species'.Accoya's exceptional performance is achieved solely by increasing the presenceof 'acetyl' in the wood - this molecule is naturally present in every woodspecies, meaning that Accoya is completely non-toxic. Accoya is distinguishedby its durability, stability and, perhaps most importantly of all, itsreliability. With performance attributes similar to or better than the besttropical hardwoods and superior to many artificial material alternatives, Accoyais particularly suitable for outdoor use. Commenting on the research Edward Pratt, CEO of Accsys, said: "Accoya(TM) ispoised to fill a gap in a market that's looking for a high performance, reliablealternative to tropical hardwoods and other materials. The combination ofAccoya and Sikkens' quality coatings makes Accoya(TM) even more attractive andwe're extremely encouraged by these results." Franck van Hooff, General Manager Sikkens Joinery Benelux, added: "Accoya'sdevelopment fits well with Sikkens' LongLifeTM concept of Joinery. In fact,customers are now asking us for maintenance-free periods of up to 10 years andthe combination of Accoya and our coatings systems will make that possible forthe first time. A further great advantage is that Accoya is produced from fastgrowing timbers from plantations, available in large quantities in Europe andother parts of the world. The felling of tropical timbers in rainforests toproduce items such as highly durable window sills will become redundant asenvironmentally friendly alternatives like these become available. This fitsvery well into our Corporate Social Responsibility strategy." Accsys' Directors believe that wood acetylation will form the Company's focus inthe short to medium term with the business plan forecasting strong growth in thenext few years. Accsys operates a large-scale pilot plant in Arnhem, theNetherlands. This plant is presently being used to supply test material tocustomers and potential licensees across the world. A full scale plantcurrently under construction is scheduled to go into production in Summer 2006. ENDS For further information, please contact: Accsys Technologies PLC William Paterson-Brown, +44 (0) 20 7598 4040 Executive Chairmanwww.accsysplc.comCollins Stewart Limited Andrew Smith / Martin Eales +44 (0) 20 7523 8000Parkgreen Communications Justine Howarth / Ana Ribeiro +44 (0) 20 7493 3713 Notes to Editors Accsys Technologies - Accsys owns the rights to a number of processes, includinghigh temperature cracking and cellulose modification. These other proprietarytechnologies are the responsibility of its International Chemical Company (ICC)subsidiary. Accsys' core technologies have either existing patent protection orpending patent applications. Accsys is focusing its energies on the launch ofits Titan Wood business: once this business has been established, the Directorsintend to pursue other technologies within its portfolio. Sikkens Joinery (Netherlands) - Sikkens Joinery (Netherlands) is a subsidiary ofAkzo Nobel and provides coating systems for the professional painter which bringinnovation, technical excellence, premium quality and high performance toarchitects, specifiers and interior designers for new and maintenanceapplications. Wood Acetylation - Wood acetylation is a process which increases the amount of 'acetyl' molecules in wood, thereby changing its physical properties. Theprocess protects wood from rot by making it "inedible" to most micro-organismsand insects, without - unlike conventional treatments - making it toxic. Italso greatly reduces the wood's tendency to swell and shrink, making it lessprone to cracking and ensuring that when painted it requires dramaticallyreduced maintenance. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
8th Jun 202610:10 amRNS-RNotice of Results & Investor Presentation via IMC
21st Apr 20267:00 amRNSTrading Update
17th Apr 20267:00 amRNSAnalyst Site Visit, Arnhem, NL
7th Apr 202611:40 amRNSStandard form for notification of major holdings
30th Mar 20267:00 amRNSChange of external auditor
30th Jan 20261:30 pmRNSTotal Voting Rights
26th Jan 20267:00 amRNSStandard form for notification of major holdings
22nd Jan 20262:00 pmRNSStandard form for notification of major holdings
16th Jan 20267:00 amRNSAccsys Employee Share Plan - Issue of Shares
11th Dec 20252:00 pmRNSStandard form for notification of major holdings
11th Dec 20257:00 amRNS-RProgressive Research Initiation Note Publication
9th Dec 20254:06 pmRNSSecondary Sale in Accsys Technologies PLC Shares
25th Nov 20257:01 amRNS-RLaunch of Accsys Sustainability Plan
25th Nov 20257:00 amRNSInterim results for six months ended 30 Sep 2025
10th Nov 20257:00 amRNSNotice of Interim Results & Investor Presentation
22nd Oct 20257:00 amRNSSuccessful Completion of Debt Refinancing
24th Sep 20255:15 pmRNSResult of AGM
24th Sep 20257:00 amRNSTrading Update
21st Jul 202510:00 amRNS2025 Annual Report and Notice of AGM
14th Jul 20257:00 amRNSDirector/PDMR Shareholding
30th Jun 202512:30 pmRNSDirector/PDMR Shareholding
24th Jun 20257:00 amRNSPreliminary results for the year end 31 March 2025
5th Jun 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
7th May 20257:00 amRNSTrading Update
2nd Apr 20257:00 amRNSAppointment of Nominated Advisor and Broker
27th Feb 20259:00 amRNSHolding(s) in Company
24th Feb 20259:00 amRNSHolding(s) in Company
24th Feb 20259:00 amRNSHolding(s) in Company
30th Jan 20257:00 amRNSInvestor Strategy Day
29th Nov 20249:00 amRNSDirector/PDMR Shareholding
27th Nov 20243:00 pmRNSDirector LTIP Award
26th Nov 20247:00 amRNSInterim results for six months ended 30 Sep 2024
6th Nov 20242:00 pmRNSNotice of Results
25th Sep 20243:00 pmRNSResult of AGM
24th Sep 20247:00 amRNSDirectorate Update
19th Sep 20247:00 amRNSHull Plant
4th Sep 20243:15 pmRNSDirector/PDMR Shareholding
4th Sep 20247:00 amRNSTrading Update
2nd Sep 20245:00 pmRNSBlock listing 6 monthly return
2nd Sep 20245:00 pmRNSTotal Voting Rights
16th Aug 20242:00 pmRNSNotice of Annual General Meeting 2024
19th Jul 20244:30 pmRNSAnnual Financial Report
19th Jul 20244:20 pmRNSDirector/PDMR Shareholding
5th Jul 20247:00 amRNSDirectorate Update
26th Jun 20247:00 amRNSPRELIMINARY RESULTS FOR THE YEAR END 31 MARCH 2024
16th May 20247:00 amRNSDirectorate Change
2nd May 20247:00 amRNSTrading Update
28th Mar 202412:00 pmRNSDirector Interests
1st Mar 20247:00 amRNSBlock listing Six Monthly return
27th Feb 20247:00 amRNSBlock listing application to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.